Werewolf Therapeutics Inc (HOWL)

02:37 AM

What analysts say about Werewolf Therapeutics Inc. stockHigh-octane gains - PrintWeekIndia

02:37 AM

02:51 AM

Is Werewolf Therapeutics Inc. stock a growth or value playHigh-octane financial growth - jammulinksnews.com

02:51 AM

Jul 24, 2025

Why Werewolf Therapeutics Inc. stock is on top investor watchlistsHigh-profit capital plays - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

Is Werewolf Therapeutics Inc. stock overhyped or has real potentialMarket-leading growth rates - jammulinksnews.com

Jul 24, 2025

Jul 23, 2025

What drives Werewolf Therapeutics Inc. stock priceSky-high return potential - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Is Werewolf Therapeutics Inc. a good long term investmentRapidly growing investment returns - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Werewolf Therapeutics Inc. Stock Analysis and ForecastSuperior stock selection - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

How Werewolf Therapeutics Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 22, 2025

Jul 22, 2025

Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Shares - Newser

Jul 22, 2025

Jul 15, 2025

What makes Werewolf Therapeutics Inc. stock price move sharplyInvestor Favorite Picks - Newser

Jul 15, 2025

Jul 10, 2025

Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know - MSN

Jul 10, 2025

Jul 10, 2025

Vontobel Holding Ltd. Acquires New Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jul 10, 2025

Jul 09, 2025

Werewolf Therapeutics to Present Innovative IL-2 INDUKINE Development at KidneyCAN 7th Annual Kidney Cancer Research Summit - Nasdaq

Jul 09, 2025

Jul 09, 2025

Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit - GlobeNewswire

Jul 09, 2025

Jul 07, 2025

Werewolf Therapeutics: A High-Risk, High-Potential Bet in Cancer Immunotherapy - criticalcontrolroomworld.com

Jul 07, 2025

Jul 05, 2025

Werewolf Therapeutics (NASDAQ:HOWL) Trading Up 1% – What’s Next? - Defense World

Jul 05, 2025

Jun 13, 2025

Werewolf Therapeutics Adopts New Bylaws and Elects Directors - TipRanks

Jun 13, 2025

Jun 13, 2025

Two Sigma Investments LP Sells 87,168 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 13, 2025

Jun 12, 2025

Werewolf Therapeutics to Participate in the BIO International Convention - GlobeNewswire

Jun 12, 2025

Jun 09, 2025

Jane Street Group LLC Acquires 39,564 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 09, 2025

Jun 08, 2025

Two Sigma Advisers LP Sells 117,200 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jun 08, 2025